These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22573625)

  • 1. The elusive biomarker for personalized medicine in multiple sclerosis: the search continues.
    Rudick RA
    Neurology; 2012 Aug; 79(6):498-9. PubMed ID: 22573625
    [No Abstract]   [Full Text] [Related]  

  • 2. Depression in multiple sclerosis associated with interferon beta-1a (Rebif).
    Pandya R; Patten S
    Can J Psychiatry; 2002 Sep; 47(7):686. PubMed ID: 12355685
    [No Abstract]   [Full Text] [Related]  

  • 3. Alemtuzumab for multiple sclerosis: who and when to treat?
    Sprenger T; Kappos L
    Lancet; 2012 Nov; 380(9856):1795-7. PubMed ID: 23128041
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS.
    Bushnell SE; Zhao Z; Stebbins CC; Cadavid D; Buko AM; Whalley ET; Davis JA; Versage EM; Richert JR; Axtell RC; Steinman L; Medori R
    Neurology; 2012 Aug; 79(6):531-7. PubMed ID: 22573631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferons beta in patients with multiple sclerosis].
    Vlasov IaV; Kuznetsova NI; Poverennova IE; Khivintseva EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):54-5. PubMed ID: 16117149
    [No Abstract]   [Full Text] [Related]  

  • 6. Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
    Salvatore E; Morra VB; Orefice G
    Neurology; 2009 Sep; 73(13):1078; author reply 1078-9. PubMed ID: 19786703
    [No Abstract]   [Full Text] [Related]  

  • 7. Widespread urticaria due to intramuscular interferon beta-1a therapy for multiple sclerosis.
    Guijarro C; Benito-León J; Bermejo-Pareja F
    Neurol Sci; 2011 Apr; 32(2):309-11. PubMed ID: 20890624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.
    Cohen JA; Coles AJ; Arnold DL; Confavreux C; Fox EJ; Hartung HP; Havrdova E; Selmaj KW; Weiner HL; Fisher E; Brinar VV; Giovannoni G; Stojanovic M; Ertik BI; Lake SL; Margolin DH; Panzara MA; Compston DA;
    Lancet; 2012 Nov; 380(9856):1819-28. PubMed ID: 23122652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients.
    Rudick RA; Kappos L; Kinkel R; Clanet M; Phillips JT; Herndon RM; Sandrock AW; Munschauer FE
    Mult Scler; 2011 Mar; 17(3):353-60. PubMed ID: 20965959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The comparative study of efficacy and tolerability of intramuscular introduction of beta-interferon-1a in adults and adolescents with remitting multiple sclerosis].
    Boĭko AN; Batysheva TT; Bykova OV; Davydovskaia MV; Demina TL; Lashch NIu; Nankina IA; Ovcharov VV; Popova EV; Popova NF; Boĭko OV; Khachanova NV; Shchur SG; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2 Pt 2):98-103. PubMed ID: 22677685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the convenience of home-based interferon beta-1a therapy for multiple sclerosis.
    Lesaux J; Jadbäck G; Harraghy CE
    J Neurosci Nurs; 1999 Jun; 31(3):174-9. PubMed ID: 10846648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of relapsing-remitting multiple sclerosis with recombinant interferon-beta preparations].
    Mäurer M; Gold R; Toyka KV; Rieckmann P
    Nervenarzt; 2001 Feb; 72(2):108-16. PubMed ID: 11256144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β.
    Balasa R; Maier S; Voidazan S; Hutanu A; Bajko Z; Motataianu A
    CNS Neurol Disord Drug Targets; 2015; 14(6):804-10. PubMed ID: 25801840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon beta therapy increases serum ferritin levels in patients with relapsing-remitting multiple sclerosis.
    Sena A; Pedrosa R; Ferret-Sena V; Cascais MJ; Roque R; Araújo C; Couderc R
    Mult Scler; 2008 Jul; 14(6):857-9. PubMed ID: 18573825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS study.
    Freedman MS; Francis GS; Sanders EA; Rice GP; O'Connor P; Comi G; Duquette P; Metz L; Murray TJ; Bouchard JP; Abramsky O; Pelletier J; O'Brien F; ;
    Mult Scler; 2005 Feb; 11(1):41-5. PubMed ID: 15732265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy.
    Trojano M; Liguori M; Paolicelli D; Zimatore GB; De Robertis F; Avolio C; Giuliani F; Fuiani A; Livrea P;
    Mult Scler; 2003 Oct; 9(5):451-7. PubMed ID: 14582768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combination therapy of beta-interferon 1a and prednisone on serum immunologic markers in patients with multiple sclerosis.
    Salama HH; Kolar OJ; Zang YC; Zhang J
    Mult Scler; 2003 Feb; 9(1):28-31. PubMed ID: 12617264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis.
    Mikol D; Lopez-Bresnahan M; Taraskiewicz S; Chang P; Rangnow J;
    Mult Scler; 2005 Oct; 11(5):585-91. PubMed ID: 16193898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized study.
    Polman C; Barkhof F; Kappos L; Pozzilli C; Sandbrink R; Dahlke F; Jakobs P; Lorenz A;
    Mult Scler; 2003 Aug; 9(4):342-8. PubMed ID: 12926838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon β-1a for multiple sclerosis: old drug, new clothes.
    Hartung HP
    Lancet Neurol; 2014 Jul; 13(7):638-9. PubMed ID: 24878062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.